Home Valsartan NDMA & Cancer Risk

NDMA-Contaminated Valsartan and Cancer Risk

The U.S. Food and Drug Administration recalled some batches of valsartan contaminated with the potentially cancer-causing agent N-nitrosodimethylamine (NDMA). The agency estimates that for every 8,000 people that took the highest dose of valsartan for four years there may be one additional case of cancer. NDMA is a known environmental contaminant found in water and foods.

Last Modified: April 28, 2021
Fact Checked
Medically Reviewed

Board-certified physicians medically review Drugwatch content to ensure its accuracy and quality.

Drugwatch partners with Physicians’ Review Network Inc. to enlist specialists. PRN is a nationally recognized leader in providing independent medical reviews.

Reviewer specialties include internal medicine, gastroenterology, oncology, orthopedic surgery and psychiatry.

People who took batches of valsartan contaminated with N-nitrosodimethylamine (NDMA), a toxic chemical contaminant, may be at an increased risk for developing cancer. Studies compiled in a report published by the World Health Organization showed that NDMA exposure has resulted in the development of tumors in animals. The report noted that the International Agency for Research on Cancer (IARC) had upgraded NDMA from “possibly carcinogenic to humans” to “probably carcinogenic to humans” based on available evidence.

A 2018 Danish study in the BMJ did not show an increase in the short-term risk of cancer in people who took the tainted valsartan. But it provides short-term reassurance only, experts say.

“There hasn't been long enough follow-up to really see a [cancer] signal. So while I'm reassured that they didn't find one, I don't think it means that patients are completely out of the woods.”

Millions of Americans take valsartan to treat high blood pressure or other heart problems. The U.S. Food and Drug Administration announced a recall of half of the supply of valsartan in the U.S. because of NDMA contamination. Cancer is not a typical side effect of valsartan, but people exposed to contaminated drugs may have a higher risk of developing cancer from NDMA exposure.

In September 2018, the FDA, European Medicines Agency and Health Canada announced it found a second cancer-causing chemical in the same family as NDMA called N-nitrosodiethylamine (NDEA).

Lawyers are filing valsartan lawsuits for people who suffered digestive tract cancers after taking valsartan. These include liver, stomach, colorectal, bladder and pancreatic cancer.

Were you or a loved one diagnosed with cancer or liver damage after taking Valsartan?

How Much NDMA Is in Valsartan?

The average NDMA levels detected in contaminated valsartan products from one supplier, Zhejiang Huahai Pharmaceuticals, was 60 parts per million (ppm). This is more than 1,000 times the amount most people consume in drinking water daily.

The Agency for Toxic Substances & Disease Registry released a public health statement in 2015 claiming that animals who suffered liver disease, cancer and death had consumed water containing 5 to 50 ppm of NDMA and food containing 5 to 100 ppm.

Zhejiang Huahai, the Chinese valsartan manufacturer, believes the NDMA contamination occurred after it changed its manufacturing process in 2012.

Amy Keller, RN | 0:56 What is valsartan’s link to NDMA and cancer?
What is valsartan’s link to NDMA and cancer? - Featuring Amy Keller, RN
Diagnosed with liver damage, tumors or cancer after taking valsartan?
Replay Video
Registered Nurse Amy Keller explains valsartan's link to NDMA and cancer.

Cancer Risk After Exposure

The FDA estimated that there would be one extra case of cancer for every 8,000 patients taking the highest dose (320 mg) of contaminated valsartan every day for four years. The European Medicines Agency offered a similar calculation of 1 in 5,000 for people treated with 320 mg daily for seven years.

Valsartan Study Fact
Danish researchers found contaminated valsartan slightly increased the risk for colorectal and uterine cancer.
Source: 2018 BMJ study

The 2018 Danish study found a low short-term risk of cancer. It followed 5,150 people with no history of cancer who started taking valsartan between Jan. 1, 2012, and June 30, 2017.

Researchers found 104 cancers in people not exposed to NDMA and 198 cancers in people exposed to tainted valsartan. But authors said researchers need more studies to determine long-term risk.

Lawsuit Information
Like Valsartan, Zantac was also found to contain unacceptable levels of NDMA. People who developed cancer after taking the drug are suing manufacturers. Learn more.
View Lawsuits

Types of Cancer Caused by Contaminated Valsartan

Exposure to NDMA can cause cancer in animals and in humans, but the EPA says there are no reports of cancer in humans. However, a study published in Occupational and Environmental Medicine found that rubber workers exposed to NDMA in factories had an increase in cancer of the esophagus, oral cavity and pharynx.

“Although there are no reports of NDMA causing cancer in humans, it is reasonable to expect that exposure to NDMA by eating, drinking, or breathing could cause cancer in humans.”

In animals, NDMA caused tumors in the liver, respiratory tract, kidneys and blood vessels. Animals exposed to NDMA suffered liver damage and cancer often leading to internal bleeding and death. Treatment for each type of cancer depends on its location and how far it has spread.

Cancers that may be associated with NDMA include:
Please seek the advice of a medical professional before making health care decisions.
Related Pages